Cite
HARVARD Citation
Oudard, S. et al. (n.d.). Multicentre randomised phase II trial of gemcitabine + platinum, with or without trastuzumab, in advanced or metastatic urothelial carcinoma overexpressing Her2. European journal of cancer. 51 (1), pp. 45-54. [Online].